Figure 2.
Effects of PCPA pretreatment (4 × 200 mg/kg/day) on performance of rats on the AST (n = 9–11 per group). PCPA-treated rats required significantly more trials to reach criterion on the R1 reversal task compared to vehicle-treated controls (*p < 0.001 compared to control rats on the same stage; +p < 0.001 compared to other tasks for the same group).